Viral ASAPseq definition of CD4+ T cell viral reservoirs

CD4 T 细胞病毒库的 Viral ASAPseq 定义

基本信息

  • 批准号:
    10634740
  • 负责人:
  • 金额:
    $ 20.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-06-03 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

While combination antiretroviral therapy (ART) effectively controls HIV viremia in most people living with HIV (PLWH), broadly applicable strategies to induce viral remission have remained elusive due to HIV reservoir persistence. Substantial progress has been made in defining the virological characteristics of the proviral reservoir of latently infected cells during ART. However, significant gaps remain in our understanding of the infected CD4+ T cells that constitute the cellular HIV reservoir that limit our ability to develop effective strategies for HIV cure. We have developed a novel high throughput 10X Genomics single cell assay to directly identify HIV infected cells via the presence of integrated proviral DNA. Termed "viral ASAPseq" [Assay for Transposase Accessible Chomatin (ATAC) Surface Antigen Profile sequencing, ASAPseq, with viral alignment, viral ASAPseq], this assay allows detection of HIV proviral DNA within euchromatin in combination with 154-marker cell surface antigen labeling, yielding multimodal single cell resolution of HIV infected cells. This assay does not require ex vivo activation to detect the presence of integrated viral DNA, thereby preserving the native state of the infected cell. We have successfully piloted this procedure in several conditions, including in vitro infected primary CD4+ T cells, primary lymph node CD4+ T cells from viremic PLWH, and peripheral blood CD4+ T cells from ART treated PLWH. We have further developed bioinformatic strategies to identify proviral DNA using autologous viral sequence alignment, define the surface marker composition of HIV infected cells, and characterize the epigenetic structure of infected cells. Thus, we are poised for the first time to gain a direct understanding of HIV reservoir composition directly ex vivo. Here we will apply this new technique to test the hypothesis that HIV infected CD4+ T cells have a cell surface or epigenetic signature distinct from uninfected CD4+ T cells in ART treated PLWH. We will further pilot a new strategy, scGETseq, capable of simultaneously and separately sequencing euchromatin and heterochromatin to distinguish and profile integrated HIV provirus within the active and latent reservoir of ART treated PLWH. Together our studies have the potential to provide the first full understanding of the unmanipulated CD4+ T cell HIV reservoir directly ex vivo.
而抗逆转录病毒联合治疗(ART)可以有效地控制大多数艾滋病毒感染者的艾滋病毒血症

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael R Betts其他文献

Dynamics of dendritic cells and T cells in HTLV-1-associated neuroinflammatory disease: implications in immunomodulatory therapies and diagnostic tools
  • DOI:
    10.1186/1742-4690-8-s1-a187
  • 发表时间:
    2011-06-06
  • 期刊:
  • 影响因子:
    3.900
  • 作者:
    Sharrón L Manuel;George Makedonas;Michael R Betts;Jay Gardner;James J Goedert;Zafar K Khan;Pooja Jain
  • 通讯作者:
    Pooja Jain

Michael R Betts的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael R Betts', 18)}}的其他基金

Multiomic strategies to assess HIV reservoir persistence
评估 HIV 储存持久性的多组学策略
  • 批准号:
    10676525
  • 财政年份:
    2023
  • 资助金额:
    $ 20.31万
  • 项目类别:
Viral ASAPseq definition of CD4+ T cell viral reservoirs
CD4 T 细胞病毒库的 Viral ASAPseq 定义
  • 批准号:
    10548385
  • 财政年份:
    2022
  • 资助金额:
    $ 20.31万
  • 项目类别:
Admin Core
管理核心
  • 批准号:
    10224004
  • 财政年份:
    2017
  • 资助金额:
    $ 20.31万
  • 项目类别:
Project 2 - Michael Betts
项目 2 - 迈克尔·贝茨
  • 批准号:
    10224008
  • 财政年份:
    2017
  • 资助金额:
    $ 20.31万
  • 项目类别:
Penn integrated Human Pancreas procurement and Analysis Program
宾夕法尼亚大学综合人类胰腺采购和分析计划
  • 批准号:
    9236460
  • 财政年份:
    2016
  • 资助金额:
    $ 20.31万
  • 项目类别:
Penn integrated Human Pancreas procurement and Analysis Program
宾夕法尼亚大学综合人类胰腺采购和分析计划
  • 批准号:
    10063635
  • 财政年份:
    2016
  • 资助金额:
    $ 20.31万
  • 项目类别:
Viral control mechanisms of HIV-specific T cells in HIV-infected lymph node
HIV感染淋巴结中HIV特异性T细胞的病毒控制机制
  • 批准号:
    9089892
  • 财政年份:
    2015
  • 资助金额:
    $ 20.31万
  • 项目类别:
Viral control mechanisms of HIV-specific T cells in HIV-infected lymph node
HIV感染淋巴结中HIV特异性T细胞的病毒控制机制
  • 批准号:
    9278105
  • 财政年份:
    2015
  • 资助金额:
    $ 20.31万
  • 项目类别:
CD4+ T and B cell mechanisms of influenza vaccine non-responsiveness in older adu
老年人流感疫苗无反应的 CD4 T 和 B 细胞机制
  • 批准号:
    8788501
  • 财政年份:
    2014
  • 资助金额:
    $ 20.31万
  • 项目类别:
CD4+ T and B cell mechanisms of influenza vaccine non-responsiveness in older adu
老年人流感疫苗无反应的 CD4 T 和 B 细胞机制
  • 批准号:
    8985652
  • 财政年份:
    2014
  • 资助金额:
    $ 20.31万
  • 项目类别:

相似海外基金

Phase I/II clinical trial of autologous T cell gene therapy to treat X-linked lymphoproliferative disease (XLP)
自体T细胞基因疗法治疗X连锁淋巴增殖性疾病(XLP)的I/II期临床试验
  • 批准号:
    MR/Y019458/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Research Grant
Fabrication and Evaluation of Poly(glycerol sebacate) based small diameter vascular graft as a potent substitution for autologous vessels
基于聚(甘油癸二酸酯)的小直径血管移植物作为自体血管有效替代品的制造和评估
  • 批准号:
    2897580
  • 财政年份:
    2023
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Studentship
Autologous Bone Marrow Aspirate Concentrate for the Treatment of Osteonecrosis of the Femoral Head
自体骨髓抽吸浓缩液治疗股骨头坏死
  • 批准号:
    10658324
  • 财政年份:
    2023
  • 资助金额:
    $ 20.31万
  • 项目类别:
Identifying multimodal biomarkers for autologous serum tears in the treatment of chronic postoperative ocular pain
识别治疗慢性术后眼痛的自体血清泪液的多模式生物标志物
  • 批准号:
    10794761
  • 财政年份:
    2023
  • 资助金额:
    $ 20.31万
  • 项目类别:
SBIR Phase II: An Injectable Protein Matrix to Enhance the Stability of Autologous Fat Grafts
SBIR II 期:可注射蛋白质基质,增强自体脂肪移植物的稳定性
  • 批准号:
    2304430
  • 财政年份:
    2023
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Cooperative Agreement
Application of Autologous Connective Tissue Sheets Created in Patients' Bodies to Pediatric Cardiac Valvuloplasty and Development of Dedicated Molds
患者体内自体结缔组织片在小儿心脏瓣膜成形术中的应用及专用模具的开发
  • 批准号:
    23K15543
  • 财政年份:
    2023
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
MICA: Strategy for heart repair in Duchenne Muscular Dystrophy (DMD) using genetically engineered autologous Mesoangioblasts
MICA:利用基因工程自体中成血管细胞修复杜氏肌营养不良症 (DMD) 的心脏的策略
  • 批准号:
    MR/X00466X/1
  • 财政年份:
    2023
  • 资助金额:
    $ 20.31万
  • 项目类别:
    Fellowship
Planning a phase I study of minor salivary gland derived autologous MSCs for prevention of long-term radiation induced xerostomia
计划对小唾液腺来源的自体 MSC 进行 I 期研究,以预防长期辐射引起的口干症
  • 批准号:
    10720234
  • 财政年份:
    2023
  • 资助金额:
    $ 20.31万
  • 项目类别:
SBIR PHASE II, TOPIC 429: A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING
SBIR 第二阶段,主题 429:自体和同种异体细胞治疗制造的新范式
  • 批准号:
    10976161
  • 财政年份:
    2023
  • 资助金额:
    $ 20.31万
  • 项目类别:
Evaluation of a therapeutic vaccination strategy with motif neoepitope peptide-pulsed autologous dendritic cells for non-small cell lung cancer patients harboring a charged HLA-B binding pocket.
使用基序新表位肽脉冲的自体树突状细胞对携带带电 HLA-B 结合袋的非小细胞肺癌患者的治疗性疫苗接种策略进行评估。
  • 批准号:
    10721983
  • 财政年份:
    2023
  • 资助金额:
    $ 20.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了